IP Library Granted Patent US 11,267,851
Granted Patent B2
US 11,267,851 · App. 16/631,133 · Granted Mar 8, 2022

Antimicrobial adhesive protein, antimicrobial nanoparticle, antimicrobial composition comprising same nanoparticle, and preparation method for same composition

Inventors: Hyung Joon Cha (Pohang-si, KR); Yun Kee Jo (Pohang-si, KR); Yeonsu Jeong (Busan, KR)
Assignees: POSCO; POSTECH ACADEMY-INDUSTRY FOUNDATION
C07K14/43504A61K9/51A61K47/54A61P31/04C07K7/06C07K7/08A61K38/00A61K45/06
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 11,267,851
App. No.
16/631,133
Granted
Mar 8, 2022
Kind
B2
Abstract

An antimicrobial adhesive protein, an antimicrobial nanoparticle, an antimicrobial composition comprising the same nanoparticle, and a preparation method for the same composition are described and, more particularly, an antimicrobial adhesive protein in which an antibiotic peptide is linked to a mussel adhesive protein, a mussel adhesive protein derivative of which a tyrosine residue within the antimicrobial adhesive protein is modified with a catechol derivative, an antimicrobial nanoparticle including a metal capable of forming a coordinate bond with a derivative of the mussel adhesive protein and having intrinsic antimicrobial activity, an antimicrobial composition comprising the same nanoparticle, and a preparation method for the same composition are described.

Claims (10)

1. An antimicrobial composition comprising an antimicrobial nanoparticle having inherent antimicrobial activity in an amount of 1.0 μg/mL to 2 μg/mL,

wherein the antimicrobial nanoparticle comprises an antimicrobial adhesive protein comprising an antibiotic peptide linked to a mussel adhesive protein derivative of which a tyrosine residue in the mussel adhesive protein is modified to a catechol derivative; and a metal capable of coordinating with the mussel adhesive protein derivative,

wherein the antimicrobial nanoparticle has an antimicrobial effect under a bacterial infection environment condition of pH 0.1 to pH 6.5.

2. The antimicrobial composition of claim 1 , wherein the catechol derivative is at least one selected from the group consisting of 3,4-dihydroxyphenylalanine (DOPA), DOPA o-quinone, dopamine, norepinephrine, epinephrine, epigallocatechin gallate and derivatives thereof.

3. The antimicrobial composition of claim 1 , wherein the metal capable of coordinating with the mussel adhesive protein derivative is at least one selected from the group consisting of titanium, vanadium, chrome, manganese, iron, cobalt, nickel, zirconium, niobium, molybdenum, technetium, ruthenium, rhodium, palladium, silver, hafnium, tantalum, tungsten, rhenium, osmium, iridium, platinum and gold.

4. The antimicrobial composition of claim 1 , wherein the antimicrobial adhesive protein is additionally loaded with an antimicrobial agent.

5. The antimicrobial composition of claim 4 , wherein the antimicrobial agent is at least one selected from the group consisting of penicillins, cephalosporins, β-lactams, macrolides, glycopeptides, lincosamides, quinolones, rifamycin, chloramphenicol, polymyxin, trimethoprim, streptogramin, oxazolidinone, gentamicin and bacitracin.

6. The antimicrobial composition of claim 1 , wherein the mussel adhesive protein is a protein selected from the group consisting of Mytilus edulis foot protein (Mefp)-1, Mefp-2, Mefp-3, Mefp-4, Mefp-5 , Mytilus galloprovincialis foot protein (Mgfp)-1, Mgfp-2, Mgfp-3, Mgfp-4, Mgfp-5 , Mytilus coruscus foot protein (Mcfp)-1, Mcfp-2, Mcfp-3, Mcfp-4, Mcfp-5, foot protein (fp)-1, fp-2, fp-3, fp-4, fp-5 and fp-6, a variant thereof, or a fusion protein to which at least one protein selected from the group is linked.

7. The antimicrobial composition of claim 1 , wherein the antibiotic peptide is at least one peptide selected from the group consisting of an Annexin A7 peptide (A7 peptide) a Tet-20 peptide, a minTBP peptide and an MP196 peptide.

8. The antimicrobial composition of claim 1 , wherein the antimicrobial composition has inherent antimicrobial activity without any additional antimicrobial agent.

Assignments (3)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Apr 4, 2023
From: POSCO HOLDINGS INC.; POSTECH ACADEMY-INDUSTRY FOUNDATION
To: POSCO CO., LTD; POSTECH ACADEMY-INDUSTRY FOUNDATION
Reel/Frame 063254/0853 →
CHANGE OF NAME Recorded Sep 28, 2022
From: POSCO
To: POSCO HOLDINGS INC.
Reel/Frame 061562/0041 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jan 15, 2020
From: CHA, HYUNG JOON; JO, YUN KEE; JEONG, YEONSU
To: POSCO; POSTECH ACADEMY-INDUSTRY FOUNDATION
Reel/Frame 051519/0085 →
Priority Claims (1)
KR 10-2017-0090691 · Jul 18, 2017 · national
Continuity (1)
Related Publication 20200231637A1 · Jul 23, 2020